Colorcon Launches Acryl-EZE II to Extend pH Range of Enteric Coatings

Article

The Acryl-EZE II works to extend Colorcon’s aqueous enteric systems by providing applications for tablets and multi-particulate dosage forms with increased enteric protection.

Colorcon announced on July 16, 2020 that it is launching the Acryl-EZE II to extend the pH range covered by its enteric coatings.

According to a company press release, the Acryl-EZE II works to extend Colorcon’s aqueous enteric systems by providing applications for tablets and multi-particulate dosage forms with increased enteric protection up to a level of pH 5.0 seen with patients taking PPIs, or when tested under fed conditions.

“This extension to the Acryl-EZE portfolio of products represents an advance in delayed-release coating technology to provide the pharmaceutical industry with added convenience for enteric coating,” said Kelly Boyer, general manager Film Coatings, Colorcon, in the press release. “Acryl-EZE formulations provide significant time savings in both development and production, while enabling targeted drug delivery across a wide pH range”.

“The formulation of enteric coatings is challenging; requiring multiple ingredients and process steps. Through Colorcon’s coating technology, this new Acryl-EZE II formulation provides simplified preparation and use, with enhanced protection up to pH 5.0 through the addition of a special top-coat,” added Dr. Ali Rajabi-Siahboomi, vice-president and chief scientific officer, Colorcon, in the press release. “Coating performance has been validated through a human volunteer study in the most challenging fed state conditions, confirming bioavailability and in-vivo performance.”

Source: Colorcon

 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Lee Cronin, founder and CEO of Chemify
Nicole Hunter, head of Global WMArchitect at Watson-Marlow Fluid Technology Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.